NovoThelium
PrivateLast Round
Grant
Aug 16, 2018
Total Funding Raised
$202,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NovoThelium operates in Healthcare & Life Sciences and is based in San Antonio, Texas. Its latest recorded funding round was a Grant round in August 2018.
NovoThelium is a biotechnology company that develops a tissue-engineered matrix for nipple reconstruction after mastectomy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovoThelium Comparables
Compare NovoThelium with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BellaSeno | 77% | |
| GenesisTissue Inc. | 77% | |
| AbbVie | 71% |
For institutional investors. Book with your work email.
NovoThelium Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 16, 2018 | ||||
| Grant | Jun 21, 2018 | ||||
| Grant | May 1, 2017 | ||||
| Grant | May 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NovoThelium Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Texas A&M Engineering Experiment Station | Grant |
| Texas Venture Labs | Grant |
| Women's Business Enterprise National Council | Grant |
| MassChallenge Israel | Grant |
| Chevron Technology Ventures | Grant |
| Texas Business Hall of Fame | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 126% MoM, reaching 1.2K.
- Jun 18, 2026
Monthly visitors grew 120% MoM.
For institutional investors. Book with your work email.
NovoThelium Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NovoThelium's valuation, stock price, and market status.
Is NovoThelium a public or private company?
NovoThelium is a private company.
What is the current stock price of NovoThelium?
NovoThelium is a private company, so its shares have no public market price. Caplight tracks NovoThelium's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NovoThelium worth (valuation)?
Valuation information for NovoThelium is not publicly available.
Can I buy NovoThelium stock?
NovoThelium shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NovoThelium's last funding round?
NovoThelium's most recent funding round was Grant on August 16, 2018.
Who are the main investors in NovoThelium?
Key investors in NovoThelium include Texas A&M Engineering Experiment Station, Texas Venture Labs, Women's Business Enterprise National Council, MassChallenge Israel, Chevron Technology Ventures.
Will NovoThelium IPO soon?
No public IPO plans have been announced for NovoThelium.
How can I track NovoThelium secondary market activity?
Caplight tracks bids, offers, and trades in NovoThelium's shares on secondary markets.